Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Finally stick to the facts .....
1 .... Let's see who gets EUA first ... we are at 103 days with ZERO communication - JJ = We look forward to the topline results from the randomized, placebo-controlled phase IIb / III study before the end of 2020. https://www.pharmasalmanac.com/articles/how-an-agile-company-addressed-the-pandemic-moving-from-psychiatric-medicines-to-a-covid-19-therapeutic
2 ..... they have GOVT money to help them complete EUA process.- .. completely wrong (and you know that!) Money from GOVT only under the condition EUA and ONLY as payment for AUTHORIZED Medi!
At the moment nothing has been watered down (on the market!) ..... and the purpose of the acquisition - merger ... we will only see.
Certainly not intended for personal consumption - my opinion!
NeuroRx and Relief Therapeutics announce continuation of RLF-100™ trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020
That is the PR and we know that the 165 are completed sometime between the end of Nov / Dec, but not exactly when ..... +/- 28 days EUA (if data is sufficient!)
So possible at any time!
Do you remember ... a few days ago RT registered a new company name - Relief Therapeutik International -
The circle is full ...... JJ is an ophthalmologist
In the current situation, I take a certain degree of caution on the part of JJ as a matter of course ... therefore also the profit sharing between the two companies, negotiated for me to be on the safe side ...
I complete your paragraph--
...Dr. Jonathan Javitt did not accept his nomination, as announced at the 2020 Ordinary General Meeting, to join the Relief Board of Directors....
--because he would have a conflict of interest in the upcoming merger!
Completely correct - and now even the dumbest must recognize the imminent merger between Swiss and USA .....
Now you can see in detail why both companies find it difficult to comment on their shareholders with some statements.
Great things are coming soon ................
One last wise sentence .... Trust is good - control is better, no one asks JJ or RT to break the Law!
Meanwhile I have to agree with FB
Delay (lack of transparency) only to benefit one's own interests ..... regardless of many ailments ............
Timeline from Gilead
April 20, 2020 - Notification of study recruitment completed (Think we had in this days - begin for us from today)
April 27, 2020 - Unblinding of the interim data
May 1st, 2020 - EUA issued for remdesivir
May 21, 2020 - Study completed
I can very well imagine that RLF / NRX proceeds in a similar way. Probably this week the PR about the full recruitment (to cash in on the supposed toad of today) and next week just before the AGM then the unblinding.
... and WITHOUT hammer news always a loss for investors. Therefore well-founded news / data MUST appear soon !!
.... on November 30th included in the index. Wait at least a few more days .....
The level of awareness will certainly increase and thus more volume over the next few days (I expect parallel news this week!)
That's the reality and point
After I've finished reading (also with my nerves) I have to realize that CEO is a disaster for us Sharholders ----- and a joke for investors .......
He has no idea how the stock market works!
The next presentation....
Relief CFO, Jack Weinstein will present today at 11:30 CET at the German Equity Forum #EKF20 in the Oslo virtual room. Join the presentation or view it later to learn more about the clinical progress of our main compound #RLF100 as a potentially transformative therapeutic option for critical #COVID19. https://lnkd.in/eP6FxR5
CapTrader
Wednesday numbers.....will see !
After the conference, Javitt is available for all participants .....
New sponsor for a few days next to Relief and NeuroX ..........
It will be an interesting day on Wednesday, November 18th.
http://worldleadinghospitals.com/our-sponsors/
Total nonsense .... Ram is authorized to throw up to 1.1 billion new shares on the market at any time (which would of course be madness - but Relief would always remain a majority of votes.
One thing is certain --- ALL currently invested are interested in a market-oriented SP
What else can an artist earn with besides new songs? (and must be careful that his distribution is first class / hopefully Play MPE ?!) No Tours .....
In this time since March - no performances, tours of the artists etc - the numbers would have to explode through MPE!
But maybe the exchange rate again ...?
Interesting studies of the inhalation of Aviptadil in Germany from the University Clinic Freiburg .....
Link for entire article
https://www.gesundheitsindustrie-bw.de/fachbeitrag/aktuell/inhalation-von-darmhormon-vip-hilft-gegen-immuntherapiebedingte-lungenentzuendung
......Not only in the intestinal epithelium, but also in the lungs and on leukocytes, there are many receptors for the VIP, which is known as the drug Aviptadil. If it is inhaled, immune-suppressing properties are found. “When you inhale Aviptadil, you get a good amount of it into your lungs,” says Müller-Quernheim, “and it doesn't even get to the intestines, where it could cause side effects.” The doctors discovered after four weeks that the Release of TNF (tumor necrosis factor), the main pro-inflammatory cytokine, in the lungs had decreased significantly. At the same time, there was an increased number of regulatory T cells. Both are urgently needed to dampen irAE pneumonitis from the lungs.
Anti-inflammatory neuropeptides
Mueller-Quernheim's team was also able to achieve success with Aviptadil in the first cancer patient who had undergone immunotherapy with checkpoint inhibitors because of a melanoma and who developed pneumonitis.......
Please no tears ... it is quite normal that after the warped increase yesterday - today (Friday ...) not a few daytraders cash in !!! Pay attention to today's volume - everything will be fine ... and better
do I remember that correctly - FDA meeting today?
Thanks and ok, a new "term" may have arisen due to insufficient research ...
Thanks, at least the article is new ....
I appreciate you and your contributions ---- but are you sure about all the information in the last few hours..Award .......
and also seen on Yahoo board --1+1=?
Found this statement on defense.gov. It for the week of 10/19 I believe. Not much information but let’s us know there could be a lot going on behind the scenes to make RLF-100 is ready to be distributed.
THERAPEUTICS DEVELOPMENT:
OWS and HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) leaders met with the Association of State and Territorial Health Officials this week to discuss future allocation and distribution plans for COVID-19 therapeutics to accelerate distribution if an FDA emergency use authorization (EUA) is granted.
Guys why dont you read the importand message short time ago on the board?!
https://nypost-com.cdn.ampproject.org/c/s/nypost.com/article/potential-covid-19-treatments/amp/
...RLF-100
Critically ill patients have also bounced back quicker thanks to RLF-100, or aviptadil, a synthetic form of a natural peptide that protects the lung. The treatment was just granted fast-track emergency use designation in the US by the FDA..
Maybe someone can explain to me why PlayMPE could become a commercial success?
The (music) world has 110% well networked and functioning sales channels with labels etc.!
This presentation and forecast numbers for 2021 (not a unique or interesting story !!!) are again lukewarm water or a wish without any outlook or credibility.
Just my opinion --- and what is Steve going to do with his son again? this thing hangs like a calamity upon this company!
Hy Guys, all in time - at the OTCQB there are completely different requirements and investors (this change brings the hammer news, logical!) -
Great!! https://twitter.com/tradingbullfool/status/1298332713787756547
Also Great!! Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19 (AVICOVID-2) BLOCKBUSTER https://clinicaltrials.gov/ct2/show/NCT04360096?cond=Aviptadil&draw=2&rank=1.........
Once more Great!! Javitt will give a keynote speech at the "20th Biotech in Europe Forum for Global Investment & Partnering" on September 21
https://www.sachsforum.com/uploads/5/1/9/6/51964431/bef_agenda.pdf
(Great Investors = OTCQB !)
things are coming .. live insert-text-here
Not really the last of the oldies!
Thanks---(The strong antibody response reported by Novavax is no surprise, said Zaks. That vaccine consists of artificial versions of proteins found on the SARS-CoV-2 virus—an approach that has worked well in other diseases.)----I believe Zaks said this very relaxed!
Look today to NOVAVAX Pre to AM - Ridiculous, also for JPM
???? Since when
Easily explained ... the insiders with the CEO have and will drive away the last shareholders with more or less brutality and degeneration. Take the company off the stock exchange and sell it to big customers for a lot of money!